i&i Biotech Fund is a Luxembourg-based venture capital firm established in 2021, specializing in investments in innovative early-stage life science companies. The firm focuses on sectors such as drug discovery, medical devices, diagnostics, and digital health. By targeting European startups, i&i Biotech Fund aims to support the development of cutting-edge technologies and healthcare solutions that can significantly impact patient care and medical advancements.
At XENO we believe biology speaks biology best. Many foundational problems in diagnostics and bioengineering are solvable if biology could just do more of the work. But current biotech isn’t smart enough. We are interested in changing the status quo by systematizing biologic units and constructing modular composition rules. We are a team of engineers and biologists with specialized expertise and common system goals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.